drugset / Trial / NCT02276625

One-visit Multi-site Intradermal Rabies Vaccination - Dose Finding

NCT02276625

Phase 2 Unknown 30 enrolled Leiden University Medical Center
RandomizedParallel-groupSingle-blindPrevention

Summary

To determine optimum dose level for a single visit multidose intradermal injection of rabies vaccine with the aim to induce immunological memory in all subjects.

Timeline

Start
2014-10
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabies vaccine Vaccine 20 % Intravenous
Subject Rabies vaccine Vaccine 40 % Intravenous
Subject Rabies vaccine Vaccine 60 % Intravenous

Indications